![Logo for Entrada Therapeutics Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F4a170-2024-07-01-09-35-31.png&w=256&q=100)
Entrada Therapeutics Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Entrada Therapeutics Inc
Access all reports
Entrada Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing a new class of medicines that target intracellular sites traditionally considered unreachable by conventional therapies. The company's proprietary Endosomal Escape Vehicle technology facilitates the efficient intracellular delivery of diverse therapeutic modalities, including RNA, antibodies, and enzymes. This approach is being applied to develop treatments for a range of diseases, particularly in neuromuscular, ocular, metabolic, and immunological areas. The company is headquartered in Boston, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Entrada Therapeutics Inc
![Duchenne : Significa](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fentrada-therapeutics-inc-corporate-presentation-41dbae6acfa04980%2F8.png&w=3840&q=75)
![Logo for Entrada Therapeutics Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F4a170-2024-07-01-09-35-31.png&w=128&q=100)
Corporate Presentation
Entrada Therapeutics Inc
![Accumulation of Exon](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fentrada-therapeutics-inc-corporate-presentation-41dbae6acfa04980%2F11.png&w=3840&q=75)
![Logo for Entrada Therapeutics Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F4a170-2024-07-01-09-35-31.png&w=128&q=100)
Corporate Presentation
Entrada Therapeutics Inc
Latest articles
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2Fbbbaafadba%2Fpontis-dackmo_strong-opinions-loosely-held.png&w=3840&q=75)
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F7455f6afd1%2Fnovo-nordisk_the-danish-pharmaceutical-titan.png&w=3840&q=75)
Novo Nordisk: The Danish Pharmaceutical Titan Revolutionizing Global Healthcare
Novo Nordisk's rise to becoming Europe's largest company, reshaping global healthcare and Denmark's economy.
5 Sep 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F5533bee49f%2Fthe-toyota-way.png&w=3840&q=75)
The Toyota Way: Revolutionizing Global Manufacturing
Explore how Toyota's Lean Manufacturing and Kaizen principles revolutionized production and quality, setting global benchmarks for excellence.
2 Sep 2024
Ticker symbol
TRDA
Country
🇺🇸 United States